These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 2058219)

  • 1. [Experimental peritoneal calcinosis--glucocorticoid as inhibitor].
    Klemm G
    Z Gesamte Inn Med; 1991 Mar; 46(4):132-3. PubMed ID: 2058219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prednisolone as a calcification inhibitor--a calciphylactic experiment in the rat pancreas].
    Klemm G; Putzke HP
    Dtsch Z Verdau Stoffwechselkr; 1983; 43(3):141-5. PubMed ID: 6884263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal changes of peritoneal function calculated by personal dialysis capacity in a patient after long-term continuous ambulatory peritoneal dialysis.
    Nakamoto H; Takane H; Sugahara S; Kanno Y; Okada H; Yamamoto T; Suzuki H
    Adv Perit Dial; 2003; 19():97-102. PubMed ID: 14763042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of peritoneal adhesions in the rat with sustained intraperitoneal dexamethasone delivered by a novel therapeutic system.
    Höckel M; Ott S; Siemann U; Kissel T
    Ann Chir Gynaecol; 1987; 76(6):306-13. PubMed ID: 3448986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the effect of uremia on peritoneal permeability in an experimental model of continuous ambulatory peritoneal dialysis in anephric rats.
    Pawlaczyk K; Kuzlan-Pawlaczyk M; Wieczorowska-Tobis K; Polubinska A; Breborowicz A; Oreopoulos D
    Adv Perit Dial; 1999; 15():32-5. PubMed ID: 10682068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of peritoneal adhesions by intraperitoneal administration of vitamin E: an experimental study in rats.
    de la Portilla F; Ynfante I; Bejarano D; Conde J; Fernández A; Ortega JM; Carranza G
    Dis Colon Rectum; 2004 Dec; 47(12):2157-61. PubMed ID: 15657668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Encapsulating peritoneal sclerosis as a serious complication of peritoneal dialysotherapy--current opinions on treatment and prevention].
    Baczyński D; Antosiewicz S; Wańkowicz Z
    Pol Merkur Lekarski; 2004 Aug; 17(98):168-70. PubMed ID: 15603330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An experimental model of encapsulating peritoneal sclerosis.
    Sawada T; Ishii Y; Nakajima I; Fuchinoue S; Kubota K; Teraoka S
    Perit Dial Int; 2009 Feb; 29 Suppl 2():S49-50. PubMed ID: 19270231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causes of peritoneal calcifications in CAPD. Reply to Kitoh et al.
    Papazov V
    Clin Nephrol; 2000 Aug; 54(2):174. PubMed ID: 10968699
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of glucose and plasminogen activator inhibitor-1 on collagen metabolism in the peritoneum.
    Higuchi C; Tanihata Y; Nishimura H; Naito T; Sanaka T
    Ther Apher Dial; 2005 Apr; 9(2):173-81. PubMed ID: 15828931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of everolimus as an antiproliferative agent on regression of encapsulating peritoneal sclerosis in a rat model.
    Duman S; Bozkurt D; Sipahi S; Sezak M; Ozkan S; Ertilav M; Sen S; Ok E
    Adv Perit Dial; 2008; 24():104-10. PubMed ID: 18986012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of an experimental rat model for peritoneal dialysis: fluid and solute transport characteristics.
    Park MS; Heimbürger O; Bergström J; Waniewski J; Werynski A; Lindholm B
    Nephrol Dial Transplant; 1994; 9(4):404-12. PubMed ID: 8084455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intraperitoneal cyclooxygenase inhibition on inflammatory mediators in dialysate and peritoneal membrane characteristics during peritonitis in continuous ambulatory peritoneal dialysis.
    Zemel D; Struijk DG; Dinkla C; Stolk LM; ten Berge IJ; Krediet RT
    J Lab Clin Med; 1995 Aug; 126(2):204-15. PubMed ID: 7636393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosiglitazone, a peroxisome proliferator-activated receptor agonist, improves peritoneal alterations resulting from an encapsulated peritoneal sclerosis model.
    Bozkurt D; Taskin H; Sezak M; Biçak S; Sen S; Ok E; Duman S
    Adv Perit Dial; 2008; 24():32-8. PubMed ID: 18985998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of postoperative adhesions by intraperitoneal medication--an experimental study.
    Qiu HD; Shi HA
    J Tongji Med Univ; 1987; 7(3):173-5. PubMed ID: 3448244
    [No Abstract]   [Full Text] [Related]  

  • 16. Histologic criteria for diagnosing encapsulating peritoneal sclerosis in continuous ambulatory peritoneal dialysis patients.
    Honda K; Nitta K; Horita S; Tsukada M; Itabashi M; Nihei H; Akiba T; Oda H
    Adv Perit Dial; 2003; 19():169-75. PubMed ID: 14763056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and ultrastructural peritoneal membrane changes and permeability alterations during continuous ambulatory peritoneal dialysis.
    Verger C; Brunschvicg O; Le Charpentier Y; Lavergne A; Vantelon J
    Proc Eur Dial Transplant Assoc; 1981; 18():199-205. PubMed ID: 7329968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of aminoguanidine on peritoneal microcirculation and tissue remodelling in a rat model of PD.
    Zareie M; Tangelder GJ; ter Wee PM; Hekking LH; van Lambalgen AA; Keuning ED; Schadee-Eestermans IL; Schalkwijk CG; Beelen RH; van den Born J
    Nephrol Dial Transplant; 2005 Dec; 20(12):2783-92. PubMed ID: 16204296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible peritoneal calcification in a patient treated by CAPD.
    Kitoh C; Miyagi K; Onoe T; Katano K; Shimada T; Takegoshi T
    Clin Nephrol; 1999 Nov; 52(5):329-32. PubMed ID: 10584998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of intraperitoneal with intravenous administration of taxol in experimental peritoneal carcinomatosis.
    Hribaschek A; Meyer F; Schneider-Stock R; Pross M; Ridwelski K; Lippert H
    Chemotherapy; 2007; 53(6):410-7. PubMed ID: 17952000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.